A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample.
A Retrospective Estimate of Ear Disease Detection Using the "Red Flags" in a Clinical Sample.
复制标题
DOI：
10.1097/aud.0000000000000561
复制
发表时间：
2018-09
期刊：
影响因子：
3.7
通讯作者：
Zapala DA
中科院分区：
文献类型：
--
作者：
Klyn NAM;Kleindienst Robler S;Alfakir R;Nielsen DW;Griffith JW;Carlson DL;Lundy L;Dhar S;Zapala DA
本研究的目的是评估两个红旗协议在检测与听力变化相关的耳部疾病的特异性和敏感性。在对来自佛罗里达马约诊所耳鼻喉科和听力科的307名成人患者的病历审查中确定了红旗症状的存在。参与者组成了一个方便的样本，为一项单独的研究招募。神经耳科医生的诊断是比较的标准。在保留用于分析的251名患者档案中，191名患有一种或多种目标疾病，60名患有与年龄或噪音相关的听力损失。美国食品药品监督管理局（FDA）的红旗灵敏度为91%（CI 86-95%），特异性为72%（CI 59-83%）。美国耳鼻喉科学会（AAO-HNS）的红旗灵敏度为98%（CI 95-99%），特异性为20%（CI 11-32%）。利益相关者必须确定哪些疾病是助听器使用的有意义的禁忌症，以及这些红旗协议是否具有可接受的灵敏度和特异性水平。随着听力设备的直接面向消费者的模式的增加，不需要提供者调解的疾病检测方法将是有用的。
The purpose of this study was to evaluate the specificity and sensitivity of two red flag protocols in detecting ear diseases associated with changes in hearing. The presence of red flag symptoms was determined in a chart review of 307 adult patients from the Mayo Clinic Florida departments of Otorhinolaryngology and Audiology. Participants formed a convenience sample recruited for a separate study. Neurotologist diagnosis was the criterion for comparisons. Of the 251 patient files retained for analysis, 191 had one or more targeted diseases and 60 had age- or noise-related hearing loss. Food and Drug Administration (FDA) red flags sensitivity was 91% (CI 86–95%) and specificity was 72% (CI 59–83%). American Academy of Otolaryngology (AAO-HNS) red flags sensitivity was 98% (CI 95–99%) and specificity was 20% (CI 11–32%). Stakeholders must determine which diseases are meaningful contraindications for hearing aid use, and whether these red-flag protocols have acceptable levels of sensitivity and specificity. As direct-to-consumer models of hearing devices increase, a disease detection method that does not require provider intercession would be useful.